1376 views | 1 decade ago
This webinar presents insight into the characterization of HIV by next-generation sequencing, including data obtained from a comparison of HIV drug-resistance variant detection in a 465-base region...
1009 views | 1 decade ago
At Illumina, we understand that as a researcher you are unique, and that your research is too. We feel the same way about our company and products. But we all have one thing in common, our drive to...
8232 views | 1 decade ago
Whole-genome sequencing conventionally generates a single consensus sequence without distinguishing between variants on homologous chromosomes. Genome phasing addresses this limitation by separating...
11865 views | 1 decade ago
At Illumina, we work on game-changing technologies that benefit human health. Our work contributes to important questions like: "Why is a person more likely to develop Type-2 diabetes?" or "Why do some...
2338 views | 1 decade ago
Illumina Cancer Webinar Series: Gad Getz, Ph.D., founder of the Cancer Genome Computational Analysis group at the Broad Institute and Director of Bioinformatics at the Mass General Cancer Center and...
705 views | 1 decade ago
Mark Van Oene, Vice President of Global Sales at Illumina, discusses the company's development of market-specific products and solutions for cancer and genetic disease.
523 views | 1 decade ago
Luis Diaz, MD, Associate Professor of Oncology at Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins, discusses the application of genomic information in a clinical manner.
1367 views | 1 decade ago
Christopher Mason, Assistant Professor in the Department of Physiology and Biomedicine at the Weill Cornell Medical College, describes how tumor evolution can be tracked by sequencing the transcriptome,...